Itraconazole is a triazole antifungal agent used to increase fungal cell membrane permeability by inhibiting ergosterol synthesis, ultimately leading to fungal cell death. Itraconazole is effective against
Blastomyces, Histoplasma, and Aspergillus species. It is used to study Candida infections in mice and to study proliferative changes in diabetic rats. Additionally, itraconazole is a hedgehog signaling inhibitor and CYP3A4 inhibitor.
Itraconazole is often used in clinical in vitro tests known as antimicrobial susceptibility tests or ASTs to determine their efficacy against certain bacterial species. They are tested against gram-negative and gram-positive bacteria using panels, discs, and MIC strips by medical microbiologists. ASTs decrease the risk of using an antibiotic against bacteria exhibiting resistance to it, and the results are used in clinical settings to determine which antibiotic(s) to prescribe for various infections.
MOLECULAR BIOLOGY GRADE
Formula: C 35H38Cl2N8O4
MW: 705.63 g/mol
Storage/Handling: Store at 4°C.
Product is soluble in chloroform.
PubChem Chemical ID: 55283